missing translation for 'onlineSavingsMsg'
Learn More

YB1 Mouse anti-Human, Clone: YBX1/2430, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-07452-100ug

 View more versions of this product

Product Code. 18699456

  • 484.00€ / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

YB1 Monoclonal specifically detects YB1 in Human samples. It is validated for Immunohistochemistry-Paraffin, Protein Array.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

YB1
Monoclonal
0.2 mg/mL
Immunohistochemistry-Paraffin 1 to 2 μg/mL, Protein Array
BP-8, CBF-A, class II, Y box-binding protein I, CSDA2, CSDB, DBPB CCAAT-binding transcription factor I subunit A, EFI-A, Enhancer factor I subunit A, MDR-NF1, MGC104858, MGC110976, MGC117250, NSEP1 Y-box-binding protein 1, nuclease-sensitive element-binding protein 1, Y box binding protein 1, YB1 DNA-binding protein B, YB-1 Y-box transcription factor, YBX1
Recombinant human full-length YB1 protein
100 μg
Breast Cancer, Cancer, DNA Repair, Epigenetics, Ovarian Carcinoma Cell Markers, Stem Cell Markers, Transcription Factors and Regulators, Translation Control
4904
Store at 4°C.
IgG2b κ
ELISA, Peptide Array
YBX1/2430
Unconjugated
10 mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.